Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Five Below Reports 9.5% Increase In Total Sales For 10-Week Period Ended July 13, 2024, But Comparable Sales Decreased By 5%; Expects Fiscal Q2 Sales Between $820M And $826M, With A 6%-7% Decrease In Comparable Sales; Diluted EPS Forecasted Between $0.53 And $0.56; To Announce Q2 Results And Discuss Q3 And Full Year Outlook When Reporting Earnings

Author: Benzinga Newsdesk | July 16, 2024 04:02pm

Posted In: FIVE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist